DAVID GRANOVSKY

Posts Tagged ‘therapy’

STEM CELLS MAKE VAGINAS!!

In SCIENCE & STEM CELLS, STEM CELLS IN THE NEWS, VICTORIES & SUCCESS STORIES on April 11, 2014 at 12:44 pm

MAKING VAGINAS FROM STEM CELLS, YES…ENTIRE VAGINAS, WORKING VAGINAS, ANATOMICALLY CORRECT IN FORM AND FUNCTION. WOW!

Georgia O'Keeffe

Georgia O’Keeffe

“Four women have had new vaginas grown in the laboratory and implanted by doctors in the US.

A tissue sample and a biodegradable scaffold were used to grow vaginas in the right size and shape for each woman as well as being a tissue match.

They all reported normal levels of “desire, arousal, lubrication, orgasm, satisfaction” and painless intercourse.

Experts said the study, published in the Lancet, was the latest example of the power of regenerative medicine.”
http://www.bbc.com/news/health-26885335

Stem Cell-based Baldness Cure One Step Closer | Beyond the Dish

In STEM CELLS IN THE NEWS on January 29, 2014 at 3:01 pm

Stem Cell-based Baldness Cure One Step Closer

http://www.mensfitness.com/sites/mensfitness.com/files/imagecache/node_page_image/article_images/male-pattern-baldness-main_0.jpg

January 28, 2014 – by mburatov

Scientists might be able to offer people with less that optimal amounts of hair new hope when it comes to reversing baldness. Researchers from the University of Pennsylvania say they’ve moved closer to using stem cells to treat thinning hair — at least in mice.

This group said that the use of stem cells to regenerate missing or dying hair follicles is considered a potential way to reverse hair loss. However, the technology did not exist to generate adequate numbers of hair-follicle-generating stem cells.

But new findings indicate that this may now be achievable. “This is the first time anyone has made scalable amounts of epithelial stem cells that are capable of generating the epithelial component of hair follicles,” Dr. Xiaowei Xu, an associate professor of dermatology at Penn’s Perelman School of Medicine, said in a university news release.

According to Xu, those cells have many potential applications that extend to wound healing, cosmetics and hair regeneration.In their new study, Xu’s team converted induced pluripotent stem cells iPSCs – reprogrammed adult stem cells with many of the characteristics of embryonic stem cells – into epithelial stem cells. This is the first time this has been done in either mice or people.

The epithelial stem cells were mixed with certain other cells and implanted into mice. They produced the outermost layers of the skin and hair follicles that are similar to human hair follicles.

This study was published in the Jan. 28 edition of the journal Nature Communications.This suggests that these cells might eventually help regenerate hair in people.

Xu said this achievement with iPSC-derived epithelial stem cells does not mean that a treatment for baldness is around the corner. Hair follicles contain both epithelial cells and a second type of adult cells called dermal papillae.

“When a person loses hair, they lose both types of cells,” Xu said. “We have solved one major problem — the epithelial component of the hair follicle. We need to figure out a way to also make new dermal papillae cells, and no one has figured that part out yet.”

Experts also note that studies conducted in animals often fail when tested in humans.

via Stem Cell-based Baldness Cure One Step Closer | Beyond the Dish.

Vitamin C boosts the reprogramming of adult cells into stem cells « Health Research Report

In STEM CELLS IN THE NEWS on January 24, 2014 at 8:05 am

November 8, 2012

Vitamin C boosts the reprogramming of adult cells into stem cells 1

http://www.nutraingredients-usa.com/var/plain_site/storage/images/publications/food-beverage-nutrition/nutraingredients-usa.com/research/vitamin-c-rda-should-be-doubled-says-linus-pauling-institute-researcher/6914603-1-eng-GB/Vitamin-C-RDA-should-be-doubled-says-Linus-Pauling-Institute-researcher_strict_xxl.jpg

Famous for its antioxidant properties and role in tissue repair, vitamin C is touted as beneficial for illnesses ranging from the common cold to cancer and perhaps even for slowing the aging process. Now, a study published online on December 24th by Cell Press in the journal Cell Stem Cell uncovers an unexpected new role for this natural compound: facilitating the generation of embryonic-like stem cells from adult cells.

Over the past few years, we have learned that adult cells can be reprogrammed into cells with characteristics similar to embryonic stem cells by turning on a select set of genes. Although the reprogrammed cells, called induced pluripotent stem cells (iPSCs), have tremendous potential for regenerative medicine, the conversion is extremely inefficient.

“The low efficiency of the reprogramming process has hampered progress with this technology and is indicative of how little we understand it. Further, this process is most challenging in human cells, raising a significant barrier for producing iPSCs and serious concerns about the quality of the cells that are generated,” explains senior study author Dr. Duanqing Pei from the South China Institute for Stem Cell Biology and Regenerative Medicine at the Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences.

Dr. Pei and colleagues measured the production of reactive oxygen species or ROS during reprogramming and discovered a potential link between high ROS and low reprogramming efficiency. They became particularly interested in antioxidants, hypothesizing that they might suppress ROS and cell senescence, which seems to be a major roadblock for the generation of iPSCs.

The researchers found that adding vitamin C, an essential nutrient that is abundant in citrus fruits, enhanced iPSC generation from both mouse and human cells. Vitamin C accelerated gene expression changes and promoted a more efficient transition to the fully reprogrammed state. Somewhat to their surprise, they found that other antioxidants do not have the same effect, but vitamin C does seem to act at least in part through slowing cell senescence.

“Our results highlight a simple way to improve iPSC generation and provide additional insight into the mechanistic basis of reprogramming,” concludes Dr. Pei. “It is also of interest that a vitamin with long-suspected anti-aging effects has such a potent influence on reprogramming, which can be considered a reversal of the aging process at the cellular level. It is likely that our work may stimulate further research in this area as well.”

via Vitamin C boosts the reprogramming of adult cells into stem cells « Health Research Report.

Pluristem stem cell trial to treat muscle injury meets main goal | Reuters

In STEM CELLS IN THE NEWS on January 22, 2014 at 5:32 pm
  • cells were safe and well tolerated
  • one group receiving a 150 million cell dose displaying a 500 percent improvement over the placebo group.
  • Patients treated with a 300 million cell dose showed a 300 percent improvement over the placebo.
  • An analysis of the gluteal muscle indicated an increase in muscle volume in those patients treated…versus the placebo group.

Pluristem stem cell trial to treat muscle injury meets main goal

TEL AVIV Tue Jan 21, 2014 3:07am EST

(Reuters) – Pluristem Therapeutics Inc said results from its early/mid-stage clinical trial indicated its placenta-derived stem cells for the treatment of muscle injury were safe and provided evidence the cells might be effective in treating orthopedic injuries.

\”Patients treated with PLX-PAD had a greater improved change of maximal voluntary muscle contraction force than the placebo group,\” Israel-based Pluristem said in a statement on Tuesday.

The trial was conducted at the Orthopedic Clinic of the Charite University Medical School under the auspices of the Paul-Ehrlich-Institute, Germany\’s health authority.

\”This was a very important study not only for Pluristem but for the cell therapy industry in general,\” Pluristem chief executive Zami Aberman said. \”Based on these results, we intend to move forward with implementing our strategy towards using PLX cells in orthopedic indications and muscle trauma.\”

The injured muscle studied was the gluteus medius muscle in the buttock. Total hip replacement surgery via the standard transgluteal approach necessitates injury of the gluteus medius muscle, and post-operative healing is crucial for joint stability and function.

\”The study showed that PLX-PAD cells were safe and well tolerated,\” the statement said.

The primary efficacy endpoint of the study was the change in maximal voluntary isometric contraction force of the gluteal muscle six months after surgery.

Efficacy was shown in two groups treated with the cells, with one group receiving a 150 million cell dose displaying a 500 percent improvement over the placebo group. Patients treated with a 300 million cell dose showed a 300 percent improvement over the placebo.

An analysis of the gluteal muscle indicated an increase in muscle volume in those patients treated with PLX-PAD cells versus the placebo group.

via Pluristem stem cell trial to treat muscle injury meets main goal | Reuters.

MS patient to take part in pioneering experiment – CBS News

In STEM CELLS IN THE NEWS on January 21, 2014 at 1:42 pm

No mention of the words “stem cell” in the headline.  No mention of stem cells until the 6th paragraph.  Why make it so difficult for patients to find these articles? In any case, we eagerly await the results! -dg

“Stem cells can be morphed into any cell in the body. Patients like Quinn have bone marrow removed and the stem cells inside are then changed in the kind of stem cells found in the brain and spinal cord.

Those cells will then be injected directly into the spinal cord. The hope is that they will repair the insulation and perhaps even the wires underneath.”

via MS patient to take part in pioneering experiment – CBS News.

 

RELATED ARTICLES:

  • FDA Approves Stem Cell Clinical Trial For Multiple Sclerosis

“To my knowledge, this is the first FDA-approved stem cell trial in the United States to investigate direct injection of stem cells into the cerebrospinal fluid of MS patients, and represents an exciting advance in MS research and treatment,” said Dr. Saud A. Sadiq, Senior Research Scientist at Tisch MS Research Center of New York and the study’s principal investigator.

The groundbreaking study will investigate a regenerative strategy using stem cells harvested from the patient’s own bone marrow.  These stem cells will be injected intrathecally (into the cerebrospinal fluid surrounding the spinal cord) in 20 participants who meet the inclusion criteria for the trial.  This will be an open label safety and tolerability study.  All study activities will be conducted at the Tisch MS Research Center and affiliated International Multiple Sclerosis Management Practice (IMSMP).”  via http://www.prnewswire.com/news-releases/fda-approves-stem-cell-clinical-trial-for-multiple-sclerosis-219553021.html

  • Meredith Vieira’s Family Health Battle

12/12/2013 – Dr Oz and Dr Tisch discuss MS and stem cells http://www.doctoroz.com/episode/meredith-vieiras-family-health-battle?

FDA-Regulated Study of Cord Blood Stem Cells to Treat Acquired Hearing Loss Launches

In SCIENCE & STEM CELLS, STEM CELLS IN THE NEWS on January 17, 2014 at 9:20 am

hearing loss

PR Newswire

SAN BRUNO, Calif., Jan. 16, 2014

Signals Potential of Newborn Stem Cells in Regenerative Medicine for Common Disorders

SAN BRUNO, Calif., Jan. 16, 2014 /PRNewswire-USNewswire/ – Cord Blood Registry® (CBR®), the world’s largest and most experienced newborn stem cell company, announces the start of a U.S. Food and Drug (FDA)-regulated study being conducted at Florida Hospital for Children in Orlando to investigate the use of a child’s stem cells from their own stored umbilical cord blood as a treatment for acquired sensorineural hearing loss.

(Logo: http://photos.prnewswire.com/prnh/20131216/DC33657LOGO-a)

In the United States, approximately 15 percent of children suffer from low or high-frequency hearing loss.[i] The most common type of hearing loss, especially at high frequencies, is sensorineural. Acquired sensorineural hearing loss results from damage to hair cells in the inner ear (cochlea) and can be caused by illness, medication, noise exposure, birth injury, or head trauma. A child’s ability to hear affects the development of language skills, and hearing impairments can lead to poor academic and social development.[ii]

The groundbreaking phase 1 study has a primary objective of determining the safety of using cord blood stem cells in a select pediatric patient population while also assessing whether this approach to treatment improves inner ear function, speech, and language development. Researchers will follow 10 children, ranging in age from 6 weeks to 6 years, who have been diagnosed with acquired hearing loss for less than 18 months and who have their own cord blood unit processed and stored under CBR’s strict quality controls. Children with a known genetic cause of deafness are ineligible for study participation. Patients will receive one intravenous infusion of their own umbilical cord blood stem cells. All patients will return for follow-up at 1 month, 6 months, and 1 year post-treatment.

The trial, supported by CBR, follows promising evidence from preclinical studies suggesting that the infusion of human umbilical cord stem cells may help repair damaged cells in the inner ear in ways that could lead to hearing improvement.[iii]

“As more children survive premature birth, we are observing increasing numbers of very young children with significant acquired hearing loss, and currently there are no therapies available for reversing that damage,” says Linda Baumgartner M.S., CCC-SLP, LSLS cert. AVT, the trial’s Speech and Language Pathologist and hearing loss expert.  James Baumgartner, MD, Surgical Director of Florida Hospital for Children’s Comprehensive Pediatric Epilepsy Center and the study’s principal investigator notes that “presently, the only treatment options for acquired sensorineural hearing loss are hearing aids or cochlear implants, neither of which actually repairs the damage. Using cord blood stem cells to help trigger the body’s own repair mechanisms could provide a non-invasive therapeutic option that does not exist today.”

During the last 25 years, cord blood stem cells have been used in more than 30,000 transplants performed worldwide for the treatment of nearly 80 serious diseases and disorders in both adults and children. The evolution of stem cell therapies has paved the way for further research being conducted through FDA-regulated clinical trials to uncover their potential in regenerative medicine applications.

“Cord Blood Registry continues to lead the industry in evaluating the potential of newborn stem cells in neurological damage, supporting FDA-regulated clinical trials in autism, cerebral palsy, pediatric stroke, traumatic brain injury, and now hearing loss,” underscores Heather Brown, Vice President of Scientific & Medical Affairs at CBR. “We are excited to learn from the outcomes of this particular study and from future studies that may evaluate broader populations affected by hearing loss or other neurological impairments for which there are limited treatment options today,” adds Brown.

For further details regarding the study, visit www.cordblood.com/hearingloss

About Cord Blood Registry

Cord Blood Registry® (CBR®) is the world’s largest newborn stem cell company. Founded in 1992, CBR is entrusted by parents with storing more than 500,000 cord blood and cord tissue units. CBR is dedicated to advancing the clinical application of newborn stem cells by partnering with leading research institutions to establish FDA-regulated clinical trials requiring CBR processed cord blood for conditions that have no cure today. For more information, visit www.cordblood.com

Florida Hospital for Children
Florida Hospital for Children is a full-service facility served by more than 130 pediatric specialists and a highly trained pediatric team of more than 1,000 caregivers and staff. This unique children’s hospital provides patients with private, family-centered pediatric rooms, a dedicated pediatric emergency department and an Advanced Center for Pediatric Surgery. The Walt Disney Pavilion at Florida Hospital for Children, in Orlando, delivers a complete range of pediatric health and research services for younger patients including advanced surgery, oncology, neurosurgery, cardiology and transplant services, full-service pediatrics, and an innovative health and obesity platform. The 200-pediatric bed facility officially opened in March 2011, but Florida Hospital has been caring for children for more than 100 years.

Contact Information:
Brian Plummer
Manager, Public Relations & Corporate Communications
(650) 635-1420 | EXT. 255
BPlummer@cordblood.com

[i] Niskar, AS, et al. Prevalence of hearing loss among children 6 to 19 years of age: the Third National Health and Nutrition Examination Survey. JAMA.1998;279:1071-1075.

[ii] Tierney, CD, et al. Development of children who have hearing impairment. Pediatr Rev 29, e72-73; discussion e73 (2008)

[iii] Revoltella RP, Papini S, Rosellini A, et al. Cochlear repair by transplantation of human cord blood CD133+ cells to nod-scid mice made deaf with kanamycin and noise. Cell Transplant.2008;17(6):665-678.

SOURCE Cord Blood Registry

STEM CELLS FIX HEART 5 YEARS AGO

In VICTORIES & SUCCESS STORIES on November 17, 2013 at 9:18 am

AN UPDATE ON JAMES 11/17/2013

 “i have been doing manual labor with my dads company the heart is doing well im getting in better shape every week.

im to the piont now i can carry 5 gallon buckets of concrete up hills lol, pretty cool still
in a few days it will be my 6 year anniversary and still no reversion!!”
success

2006

Case Study: James Eilert, 34 years old, presents with a “widowmaker” [100 % blockage of the left ascending coronary artery]. His ejection fraction (EF – volume of blood his heart pumps out) was between 20 and 25 percent (55 is normal). His cardiologist told him he has about 5 years left to live.  James left the country in order to receive Adult Stem Cell treatment.

1 1/2 weeks after treatment – Echocardiogram revealed that his completely dead apex was beating again.

6 months after treatment – Sidewalls of heart beat normally.  Septum went from 100% damage to 30% damage. Cardiologist confirms James’ heart is 50 percent more elastic than the year before Repair Stem Cell therapy.

6 – 9 months after treatment – James’ total dead heart tissue is down to about 10%.  EF is up to 50%!

4 years later – James’ heart and health continue to improve. He continues to push himself and his limits.  He runs regularly, works 7 days a week and can bike 20 miles .

Summation:

James went from Class III congestive heart failure to Class I with an ejection fraction (EF) increase from ~20-25% to his current EF of 50%.  His doctors have lifted all restrictions and limitations on his physical activities.

James is only one of many adult stem cell treatment success stories…

November 17, 2011 Update:

A letter from James.  How is he doing today?

“its amazing how fast reality can change, the differences that you see in others that they dont notice themselves. the changes in attitudes and perceptions that the “new” was never in doubt and is accepted as if it were always true. the new studies showing the truth about adult stem cell heart treatments the last few months have proven that we the few pioneers that have made huge financial sacrifices to try and save our lives were not crazy, stupid or otherwise deluded!

it was a risk and for the last four years despite proving over and over by running uphill on so many treadmills my improvments were basically ignored by cardiologists, general practitioners, and even my own wife and stepdaughters.

that i am happy to say has changed!!!!

i went to see my doctor yesterday, he told me to start heavy weight training and interval running, to help me lose weight better. what was differnet? nobody has told me to do that since my heart attack, there was no mention of taking it easy, in fact before i was told to only do light weights and take it easy, watch my heart rate, dont push past 150bpm ever.

it was like i never even had a heart attack.

i asked in disbelief if i should watch my heart rate, keep it a safe zone. the answer “no, stick to 85 to 90 percent and youll be fine, your exercise scores and echos show you can handle it”

vindication, no longer an unexplained anamoly, just a patient that responded better than average to a new treatment – like it was always true in thier minds, never a doubt.

what a feeling!! it has taken ten years to go from the “fringe” to the mainstream - i look forward to getting treatments here in america, and i’m so happy i took the risk that now ensures i will be alive to reap the benifits when it becomes available here!

have a good day david – it nice to be right once in a while!
jim eilert

Congratulations as always Jim!  On your heart recovery success and on having the courage to be a pioneer with an adult stem cell treatment that was cutting edge around the world 5 years ago and is still barely know today in the USA! – David

Stem cell scarring aids recovery from spinal cord injury

In VICTORIES & SUCCESS STORIES on November 5, 2013 at 2:45 pm

Scarring created by stem cells at the site of spinal cord injury actually assists in healing, instead of impeding it as previously thought! -dg

Stem Cell Scarring Aids Recovery from Spinal Cord Injury

Oct. 31, 2013 — In a new study, researchers at Karolinska Institutet in Sweden show that the scar tissue formed by stem cells after a spinal cord injury does not impair recovery; in fact, stem cell scarring confines the damage. The findings, which are published in the scientific journal Science, indicate that scar tissue prevents the lesion from expanding and helps injured nerve cells survive…

Stem cell scarring aids recovery from spinal cord injury.

STEM CELLS 101 – short

In ALL ARTICLES, SCIENCE & STEM CELLS on April 11, 2013 at 12:50 am

Transplanted adult dermal stem cells / Cellule...

STEM CELLS 101 – short

ADULT STEM CELL = ASC

  • SOURCE/DERIVED FROM•comes from
    blood, umbilical cords, bone marrow, placenta fat tissue, muscle, nasal
    neurological, breast milk, menstruation, dental pulp, lungs (new source!) and many more
  • PURPOSE IN BODY•they are the body’s natural healing cells
  • OBSTACLES+SIDE EFFECTS•~zero problems (virtually zero side effects)
  • TREATMENT HISTORY•used in bone marrow transplants to treat cancer for 40 years
  • TREATMENT HISTORY•can currently treat 130+ diseases safely and effectively (CP, MS, Autism, Diabetes, CHF, PAD, etc)

EMBRYONIC STEM CELL = ESC

  • SOURCE/DERIVED FROM•comes from embryos
  • PURPOSE IN BODY•split for 7 weeks until you have a fetus the size of a thumbnail
  • OBSTACLES+SIDE EFFECTS•they create
    cysts and tumors, rejection requires immunosuppressive drugs for the ill
    patient, they carry the genetic anomalies of the donor, etc
  • TREATMENT HISTORY•can currently treat zero diseases, probably need to cure cancer first to use them

INDUCED PLURIPOTENT STEM CELL = iPSC (“Embryonic Stem Cell Lite”)

  • SOURCE/DERIVED FROM•comes from regular adult cells like skin cells that are then transformed by scientists into stem cells
  • PURPOSE IN BODY•to be a skin cell or other tissue
  • OBSTACLES+SIDE EFFECTS•they create
    cysts and tumors, rejection requires immunosuppressive drugs for the ill
    patient, they carry the genetic anomalies of the donor…
  • TREATMENT HISTORY•no treatments to date, probably need to cure cancer first to use them

Benefits of PRPs in Stem Cell Therapy

In ALL ARTICLES, SCIENCE & STEM CELLS on April 9, 2013 at 7:29 pm

https://repairstemcell.files.wordpress.com/2009/02/prp.jpg?w=173&h=225

Here are the benefits of PRPs…

A few scientific studies:

  1. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819709/
  2. http://www.sciencedirect.com/science/article/pii/S0142961203001145
  3. http://informahealthcare.com/doi/full/10.3109/00207454.2012.742077
  4. http://www.sciencedirect.com/science/article/pii/S1465324912000060
  5. http://www.ingentaconnect.com/content/cog/ct/2013/00000022/00000003/art00005
  6. http://onlinelibrary.wiley.com/doi/10.1002/jcp.20391/full
  7. http://onlinelibrary.wiley.com/doi/10.1002/jbm.b.32808/full

 

Anecdotal:

  1. https://repairstemcell.wordpress.com/2011/10/10/jarvis-greens-adult-stem-cell-treatment-changed-his-life/
  2. https://repairstemcell.wordpress.com/2013/02/14/prp-treatments-show-great-potential/

 

Background:

  1. https://repairstemcell.wordpress.com/2009/02/26/prp-part-1-hines-wards-incredible-receptionprior-to-the-superbowl/
  2. https://repairstemcell.wordpress.com/2009/02/26/prp-part-2-horses-and-humans/
  3. https://repairstemcell.wordpress.com/2009/02/26/prp-part-3-horsing-around-with-stem-cells/
  4. https://repairstemcell.wordpress.com/2009/02/26/prp-part-4-prp-science-a/
  5. https://repairstemcell.wordpress.com/2009/02/26/prp-part-5-prp-science-b/
  6. https://repairstemcell.wordpress.com/2009/02/26/prp-part-6-prp-vs-blood-doping/
  7. https://repairstemcell.wordpress.com/2009/02/26/prp-part-7-regulating-prp-thrapy-in-sports/

 

Follow

Get every new post delivered to your Inbox.

Join 1,186 other followers

%d bloggers like this: